A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.
Shannon Miller, a seven-time Olympic medalist, was diagnosed with ovarian cancer at 33 after missing three warning signs ...
Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to ...
Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda prove to ...
B ERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...
Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025Program will feature ...
Former Victoria's Secret model Bianca Balti claimed that the the fashion brand denied her request to walk in the 2025 ...
Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-a | A Keytruda-based regimen has shown a statistically significant overall survival ...
Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...
Emily Pwee, 54, developed a fever and cough on Oct. 10, her husband, 54-year-old Jimmy Teo, told Shin Min Daily News . Teo, a ...
Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...
Three years after beating cancer, a senior physician suffered a serious bout of pneumonia that left her hospitalised.Dr Emily ...